THE D MAJOR GROUP for CVS CAREMARK
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Advocate for the protection of pharmaceutical benefit management and resulting cost savings.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Taxation/Internal Revenue Code TAX
Advocate for a lower domestic corporate rate resulting in increased economic investment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Health Issues HCR
Engage with policymakers on proposals related to pharmaceutical pricing, including issues related to H.R. 2430, the FDA Reauthorization Act of 2017; S. 934, the Food and Drug Administration Reauthorization Act; and S. 974, the CREATES Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Medicare/Medicaid MMM
Monitor policy matters related to H.R. 1628, the American Health Care Act of 2017; and the Better Care Reconciliation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.